ResMed Financial Indicators Patterns

RMD -- USA Stock  

USD 117.39  0.02  0.0002%

Use fundamental data analysis to confirm all available drivers of ResMed to find out if markets are presently mispricing the firm. We found thirty-eight available financial ratios for ResMed which can be compared to its competitors. To make sure the equity is not overpriced, please check all ResMed fundamentals including its Revenue, Current Ratio, Market Capitalization, as well as the relationship between Cash and Equivalents and Earnings Per Share . Given that ResMed has Price to Earning of 50.61X, we recommend you check out ResMed recent market performance to make sure the company can sustain itself down the road. Use ResMed to protect your portfolios against small markets fluctuations. The stock experiences normal downward trend and little activity. Check odds of ResMed to be traded at $116.22 in 30 days.
Enterprise Value

ResMed Company Summary

ResMed competes with DENTSPLY SIRONA, Stryker, Teleflex Incorporated, and Varian Medical. ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California. ResMed operates under Medical Instruments Supplies classification in USA and is traded on New York Stock Exchange. It employs 6000 people.

ResMed Short Ratio vs Return On Equity

ResMed is rated below average in short ratio category among related companies. It is rated below average in return on equity category among related companies reporting about  6.17  of Return On Equity per Short Ratio.

ResMed Systematic Risk

The output start index for this execution was twelve with a total number of output elements of twenty-seven. The Beta measures systematic risk based on how returns on ResMed correlated with the market. If Beta is less than 0 ResMed generally moves in the opposite direction as compared to the market. If ResMed Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one ResMed is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of ResMed is generally in the same direction as the market. If Beta > 1 ResMed moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.

Distress Rating

ResMed Financial Distress Probability

1%
Chance of Financial Distress
ResMed has less than 1 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

ResMed Thematic Clasifications

Active Themes With ResMed

Obamacare Repeal Idea
Obamacare RepealView
Drugs Idea
DrugsView

ResMed Opportunity Range

January 18, 2019 Opportunity Range

Additionally take a look at Your Equity Center. Please also try Piotroski F Score module to get piotroski f score based on binary analysis strategy of nine different fundamentals.
Search macroaxis.com